Browse studies

Find your next paid study

56 recruiting studies matching your filters

Evaluation of Children With Endocrine and Metabolic-Related Conditions

Background: Endocrine glands give off hormones. Researchers want to learn more about the disorders that affect these glands in children. These disorders might…

Adrenal InsufficiencyGrowth DisorderEndocrine Diseases+2 more

Estimated

~$10 – $675

Actual pay is set by the research site.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NCT02769975

Phase 3

A Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children With Growth Hormone Deficiency in the First Year of Treatment

A prospective, randomized, open-label single-blinded study of 50 subjects with growth hormone deficiency, ages 5 to 15 years in which 25 subjects will initiate…

Growth DisordersGrowth FailureGrowth Hormone Treatment+1 more

Estimated

~$50 – $2,250

Actual pay is set by the research site.

Northwell HealthNCT06103513

Observational

GROWTH AND TOLERANCE OF A NEW INFANT FORMULA USING AN EXTENSIVELY HYDROLYZED CASEIN-BASED PROTEIN (eHCF)

This is a research study to compare an investigational infant formula against a currently marketed infant formula. An investigational infant formula is one tha…

Growth

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Mead Johnson NutritionNCT07513506

Phase 3

A Multicenter, 12-Month, Randomized, Double Blind, Placebo-Controlled Phase 3 Efficacy and Safety Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Growth Hormone Deficiency (GHD)

The OraGrowtH Phase 3 Trial is a multi-national trial. The goals of the trial are to study LUM-201 as a treatment for Pediatric Growth Hormone Deficiency (PGHD…

Growth Hormone Deficiency (GHD)

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Lumos PharmaNCT06948214

Improving Growth and Neurodevelopment of Very Low Birth Weight Infants Through Precision Nutrition: The Optimizing Nutrition and Milk (Opti-NuM) Project

Early nutrition critically influences growth, neurodevelopment and morbidity among infants born of very low birth weight (VLBW), but current one-size-fits-all …

Very Low Birth Weight BabyEarly Nutrition and the Preterm InfantNutritional Requirements+5 more

Estimated

~$10 – $750

Actual pay is set by the research site.

The Hospital for Sick ChildrenNCT06870981

Phase 2

SERIES: SEquencing Sacituzumab Govitecan AfteR T-DXd In ER+/HER2 LOW/ULTRA LOW MetaStatic Breast Cancer

The purpose of this research study is to see if the medication sacituzumab govitecan (SG) is effective at the currently approved dose and schedule in people wh…

Breast CancerMetastatic Breast CancerAdvanced Breast Cancer+2 more

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Reshma L. Mahtani, D.O.NCT06263543

Phase 2

Phase II Minimal Residual Disease Study of Selective Estrogen Receptor Degrader Imlunestrant With Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Abemaciclib in Patients With ER+ Breast Cancer (MIRI)

This phase II trial studies how well imlunestrant and abemaciclib work in treating patients with estrogen receptor positive (ER+) breast cancer who have tumor …

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+3 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Jonsson Comprehensive Cancer Center

A Prospective, Non-interventional (NIS), Long-term, Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

The goal of this study is to further characterise the potential long-term safety risks of lonapegsomatropin in patients treated with lonapegsomatropin under re…

Growth Hormone Deficiency

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Ascendis Pharma Endocrinology Division A/SNCT05775523

MRI Assessment of Placental Health

The ultimate goal of this project is to develop methods that allow informed decision-making on the delivery time of fetuses that are at increased risk of still…

Intrauterine Growth Restriction

Estimated

~$10 – $750

Actual pay is set by the research site.

Boston Children's HospitalNCT02297724

Phase 1

A Phase 1/2 Open-label Intrathecal Administration of MELPIDA to Determine Its Safety and Efficacy for Patients With Spastic Paraplegia Type 50 (SPG50) Caused by Mutation in the AP4M1 Gene.

MELPIDA is proposed for the treatment of subjects with SPG50 and targets neuronal cells to deliver a fully functional human AP4M1 cDNA copy via intrathecal inj…

Spasticity, MuscleMicrocephalyIntellectual Deficiency+3 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Elpida Therapeutics SPCNCT05518188

Phase 2

An Extension Study to Monitor Long-Term Safety of LUM-201 Treatment in Children With Idiopathic Growth Hormone Deficiency

This is a multi-national trial. The trial aims to study the long-term safety of LUM-201 in subjects with Idiopathic Pediatric Growth Hormone Deficiency (iPGHD)…

Growth Hormone Deficiency

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Lumos PharmaNCT05796440

Phase 2

A Phase II Multi-Center Open-label Randomized Study of CAPecitabine in Combination With ELAcestrant Versus Capecitabine Alone in Advanced Estrogen Receptor-Positive Breast Cancer (CAPELA)

The goal of this research study is to compare a combination of two drugs, capecitabine and elacestrant to capecitabine alone as a treatment for advanced estrog…

Estrogen-receptor-positive Breast CancerMetastatic Breast CancerBreast Cancer+6 more

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Kristina A. FanucciNCT07222215